ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Minmin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2266-0515; OpenAlex author ID A5100699701. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Protocol for isolating high-quality nuclei from FFPE pancreatic cancer sections and constructing sequencing libraries. Last author DOI 10.1016/j.xpro.2026.104880 ↗
Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.drup.2024.101115 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huiheng Ning · 1 shared paper, 2026 · strength 0.36
- Paper Protocol for isolating high-quality nuclei from FFPE pancreatic cancer sections and constructing sequencing libraries. DOI 10.1016/j.xpro.2026.104880 ↗
Gordon Brent Mills · 1 shared paper, 2024 · strength 0.20
- Paper Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2024.101115 ↗
Lusheng Wei · 1 shared paper, 2024 · strength 0.20
- Paper Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2024.101115 ↗
Min Yu · 1 shared paper, 2024 · strength 0.20
- Paper Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2024.101115 ↗
Wei-Feng Hong · 1 shared paper, 2024 · strength 0.20
- Paper Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2024.101115 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.